drugset / Trial / NCT04581447
Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care
Phase 3
Recruiting
126 enrolled
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This study is a randomized trial that evaluates the effect of metformin addition or not to standard care on the duration of diabetes remission after bariatric surgery.
Timeline
- Start
- 2021-01-07
- Primary completion
- 2026-07
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 850 mg | — |